ES554286A0 - Un procedimiento para la preparacion de nuevos derivados glicopepticos - Google Patents

Un procedimiento para la preparacion de nuevos derivados glicopepticos

Info

Publication number
ES554286A0
ES554286A0 ES554286A ES554286A ES554286A0 ES 554286 A0 ES554286 A0 ES 554286A0 ES 554286 A ES554286 A ES 554286A ES 554286 A ES554286 A ES 554286A ES 554286 A0 ES554286 A0 ES 554286A0
Authority
ES
Spain
Prior art keywords
glycopeptic
derivatives
procedure
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554286A
Other languages
English (en)
Other versions
ES8706725A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES554286A0 publication Critical patent/ES554286A0/es
Publication of ES8706725A1 publication Critical patent/ES8706725A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K9/00—Tenebrescent materials, i.e. materials for which the range of wavelengths for energy absorption is changed as a result of excitation by some form of energy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES554286A 1985-04-25 1986-04-23 Un procedimiento para la preparacion de nuevos derivados glicopepticos Expired ES8706725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72673185A 1985-04-25 1985-04-25

Publications (2)

Publication Number Publication Date
ES554286A0 true ES554286A0 (es) 1987-07-01
ES8706725A1 ES8706725A1 (es) 1987-07-01

Family

ID=24919774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554286A Expired ES8706725A1 (es) 1985-04-25 1986-04-23 Un procedimiento para la preparacion de nuevos derivados glicopepticos

Country Status (15)

Country Link
EP (1) EP0201251A3 (es)
JP (1) JPS61251699A (es)
KR (1) KR870001282B1 (es)
CN (1) CN86103330A (es)
AU (1) AU587615B2 (es)
DK (1) DK188486A (es)
ES (1) ES8706725A1 (es)
GR (1) GR861071B (es)
HU (1) HU204854B (es)
IL (1) IL78597A0 (es)
NZ (1) NZ215947A (es)
PH (1) PH23900A (es)
PT (1) PT82445B (es)
SU (1) SU1586521A3 (es)
ZA (1) ZA863091B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701872D0 (en) * 1987-01-28 1987-03-04 Lepetit Spa N15-alkyl & n15,n15-dialkyl derivatives
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b
GB8711066D0 (en) * 1987-05-11 1987-06-17 Lepetit Spa Teicoplanin derivatives
GB8817053D0 (en) * 1988-07-18 1988-08-24 Lepetit Spa Process for preparing n15 n15-dialkyl derivatives of teicoplanin compounds
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
NZ270387A (en) * 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
AU701463B2 (en) * 1995-07-05 1999-01-28 Sanofi Aventis S.P.A. Purification of dalbaheptide antibiotics by isoelectric focusing
EP1276759B1 (en) 2000-05-02 2008-07-30 Theravance, Inc. Reductive alkylation process on glycopeptides
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
WO2006057303A1 (ja) 2004-11-29 2006-06-01 National University Corporation Nagoya University グリコペプチド抗生物質モノマー誘導体
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
AU2008342149A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivative
WO2016007855A1 (en) * 2014-07-10 2016-01-14 The Scripps Research Institute N- (hydrophobe-substituted) vancosaminyl [ψ[c(=nh) nh] tpg4] vancomycin and [ψ[ch2nh]tpg4] vancomycin
CN105985412A (zh) * 2015-02-28 2016-10-05 爱斯医药科技(南京)有限公司 万古霉素衍生物、制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462942A (en) * 1982-07-30 1984-07-31 Eli Lilly And Company A47934 Antibiotic and process for production thereof
ZA839269B (en) * 1982-12-20 1985-07-31 Lilly Co Eli Antibiotic a51568 factors a and b
DE3572178D1 (en) * 1984-04-16 1989-09-14 Lilly Co Eli Improvements in and relating to antibiotics m43a, m43b, m43c and m43d

Also Published As

Publication number Publication date
DK188486D0 (da) 1986-04-24
NZ215947A (en) 1988-10-28
SU1586521A3 (ru) 1990-08-15
KR870001282B1 (ko) 1987-06-30
EP0201251A3 (en) 1987-12-16
PT82445B (pt) 1988-11-30
EP0201251A2 (en) 1986-11-12
CN86103330A (zh) 1986-10-29
KR860008210A (ko) 1986-11-14
JPS61251699A (ja) 1986-11-08
IL78597A0 (en) 1986-08-31
DK188486A (da) 1986-10-26
PH23900A (en) 1989-12-18
AU5659886A (en) 1986-10-30
HUT40683A (en) 1987-01-28
ZA863091B (en) 1987-12-30
AU587615B2 (en) 1989-08-24
HU204854B (en) 1992-02-28
GR861071B (en) 1986-08-21
ES8706725A1 (es) 1987-07-01
PT82445A (en) 1986-05-01

Similar Documents

Publication Publication Date Title
ES557743A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
ES556101A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES557215A0 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES556026A0 (es) Un procedimiento para preparar derivados de tienopiridona
ES554609A0 (es) Un procedimiento para la preparacion de derivados de oxindol
ES557413A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato
ES548033A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES552091A0 (es) Un procedimiento para preparar derivados arilicos de dienamidas
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES551755A0 (es) Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos
ES557427A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES557019A0 (es) Un procedimiento para la preparacion de derivados aminicos
ES548960A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES541277A0 (es) Procedimiento para la preparacion de un nuevo derivado de lafructosa
ES557267A0 (es) Un procedimiento para la preparacion de derivados amidinofenilicos
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES548147A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES555109A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanodiona.
ES553605A0 (es) Un procedimiento para la preparacion de derivados de carbpenem
ES556468A0 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
ES544558A0 (es) Un procedimiento para la preparacion de derivados de dihi- dropiridina